Illustration of pembrolizumab (marketed under the name Keytruda), a drug that treats various types of cancers. Pembrolizumab is a therapeutic antibody that binds to and blocks programmed cell death protein 1 (PD-1) located on lymphocyte white blood cells.

px px dpi = cm x cm = MB
Details

Creative#:

TPG35143117

Source:

達志影像

Authorization Type:

RF

Release Information:

須由TPG 完整授權

Model Release:

N/A

Property Release:

N/A

Right to Privacy:

No

Same folder images:

Same folder images